METHOD OF PREPARING BASEMENT MEMBRANE

Description

Technical Field

[0001] The present invention relates to: a method for preparing a basement membrane which is extracellular matrices having a function to control morphology, differentiation, proliferation, motility, function expression and the like of cells; a tissue model which can be obtained by the above-mentioned method for preparing a basement membrane; a test tissue kit including said tissue model (hereinafter referred to as "the present invention 1").

Background Art

[0002] An epithelial tissue, which is a cell layer covering the inside and outside surface of an animal body, such as an epidermis, a corneal epithelium, an alveolar epithelium, a mucosal epithelium of digestive system, renal glomerular epithelium, hepatic parenchymal cells and the like, prevents the invasion of an exogenous material (microorganism, allergen, chemical substance, etc.) from the external world. The outer interface of epithelial cells that constitutes said epithelial tissue is called apical, and the inside undersurface is called basal. Just beneath said basal surface, there is a thin film structure of 50 - 100 nm thickness called a basement membrane comprised of extracellular matrices (ECM) such as proteins, proteoglycans and the like (not including cells). A basement membrane is considered to be an essential structure for immature epithelial cells to proliferate, to differentiate into mature cells, and to express its original morphology or function. In other words, without abasement membrane, an epithelial tissue cannot maintain itself or achieve its original performance. Although an epithelial cell layer of multilayer or monolayer prevents the invasion of an exogenous material from the external world as a barrier, a basement membrane itself also acts as a physical barrier. Thus, epithelial cells comprising an epithelial tissue collaborate with a basement membrane to form a solid barrier and to protect the internal vital activity.

[0003] A basement membrane, which is a specific membranous structure of extracellular matrices formed on the interface of parenchymal cells, such as epithelial cells, endothelial cells, muscle cells, adipocytes, Schwann cells and the like, and connective tissue, is universally found in respective tissue/organ of a living body, however, some basement membranes (?) are highly specialized such as a renal glomerular capillary loop, a nervous synapse membrane and the like. Therefore, not only its function to adhere cells to an interstitium, but also its function to selectively permeate a substance/cells, and to induce the differentiation of cells are also disclosed. In renal glomerulus , negative electric charge of a basement membrane is considered to be responsible for the filtration function of kidney, and said negative electric charge is traditionally known to be charged by heparan sulfate proteoglycan (HSPG) which is currently called perlecan. HSPG is widely distributed not only to a renal glomerular basement membrane but also to various basement membranes as its basic component in the same manner as type IV collagen, laminin, entactin and the like.

[0004] An extracellular matrix, especially a basement membrane, is now gradually known to be deeply involved not only in physiological phenomena such as generation or differentiation of an individual as mentioned above, but also in formation of pathology such as proliferative metastasis of cancer, inflammation and the like. Therefore, clarification of the function of its constituent protein has been an important task. For example, laminin, which is a main glycoprotein of a basement membrane, is a complex comprised of three subunits α, β, and γ, fifteen types of its isoforms are known, and they are expressed tissue-specifically and at each step of development. Laminin is a complicatedmacromolecule of 900, 000 molecular weight having various bioactivities, and over 20 types of laminin receptors are reported.

[0005] The interaction between a component of a basement membrane, which is a thin extracellular matrix layer wherein cells can be adhered, and epithelial cells influences the cell function such as migration, proliferation, differentiation and the like (Crouch et al. , Basement membrane. In The Lung (ed. R. G. Crystal and J. B. West), pp53.1-53.23. Philadelphia : Lippincott -Raven. 1996). As for the main components of abasement membrane, laminin, type IV collagen, heparan sulfate proteoglycan (HSPG), and entactin are known as mentioned above (Curr. Opin. Cell Biol. 6, 674-681, 1994), and mesenchymal cells are considered to play an important role for the synthesis of a basement membrane component including isoform of laminin and type IV collagen (MatrixBiol. 14, 209-211, 1994; J. Biol. Chem. 268, 26033-26036, 1993), however, the role of epithelial cells is also important. HSPG is believed to have been derived from epithelial cells, however, laminin, type IV collagen, and entactin are synthesized in vivo by both of epithelial cells and mesenchymal cells (Development 120, 2003-2014, 1994; Gastroenterology 102, 1835-1845, 1992). Many attempts have been made to construct an epithelial tissue model in vitro showing a continuous lamina densa. Tissue models of intestine (J. Cell Biol. 133, 417-430, 1996) and skin (J. Invest. Dermatol. 105, 597-601, 1995; J. Invest. Dermatol. 109, 527-533, 1997; Dev. Dynam. 197. 255-267, 1993) and the like have been studied, and some of basement membrane components derived from mesenchymal cells have been found to play an important role in the formation of a basement membrane.

[0006] Several methods to constitute a basement membrane by culturing epithelial cells, and to constitute epithelial cells wherein a basement membrane structure is present just beneath the basal surface have been reported. For example, the present inventors have reported that a basement membrane can be formed in vitro by coculturing alveolar epithelial cells and pulmonary fibroblasts (Cell Struc. Func., 22: 603-614, 1997). It has been reported that: if pulmonary fibroblasts, being embedded in type I collagen gel, were cultured, the collagen gel was contracted and be came more solid by pulmonary fibroblasts, and extracellular matrices being secreted and adsorbed to collagen fiber around the cells and deposited; such contracted collagen gel by fibroblasts is called a pseudointerstitium since it is similar to an interstitium in vivo; and if type II alveolar epithelial cell lines (SV40-T2) were cultured on such a pseudointerstitial tissue for approximately 14 days (T2-Fgel), basement membrane components such as type IV collagen, laminin and the like in extracellular matrices secreted by pulmonary fibroblasts were diffused in a culture medium and reached to the basal surface of the above-mentioned type II alveolar epithelial cell lines, and used as amaterial for the constitution of a basement membrane, and as a result, a basement membrane structure was formed.

[0007] It is also reported that dilute neutral collagen solution was incubated at 37° C in 5% CO₂, and collagen fiber was formed, then air-dried collagen fibrous matrix (fib) which was air-dried in aseptic condition was used as an alternative for the above-mentioned pseudointerstitium in a same manner as the above-mentioned coculture of alveolar epithelial cells and pulmonary fibroblasts to form a basement membrane (Eur. J. Cell Biol., 78:867-875, 1999; J. Cell Sci., 113:859-868, 2000). In this process, if the concentration of collagen solution is high, there will be less or no gap in fibrous collagen matrix formed, and if epithelial cells are cultured for a long term (10 days - 2 weeks) for the purpose of forming a basement membrane, cells are detached and floated (e.g. Becton Dickinson, Fibrous collagen coat culture insert), therefore, the concentration of collagen solution is considered to be optimum at 0.3 - 0.5 mg/ml (Eur. J. Cell. Biol., 78:867-875, 1999; J. Cell Sci., 113:859-868, 2000).

[0008] Type II alveolar epithelial cell lines (SV40-T2) were cultured on fibrous collagen matrix wherein Matrigel (the registered trademark of Becton Dickinson) was added, instead of using collagen matrix wherein fibrous cells were embedded. In this case, Matrigel functioned as an exogenous resource of basement membrane components. Matrigel is amixture of basement membrane components extracted from Engelbreth-Holm-Swarm tumor matrix (J. Exp. Med. 145, 204-220, 1977) , and contains laminin-1, entactin, type IV collagen, and perlecan, as well as various cytokines that possibly influence the ECM synthesis (Exp. Cell Res. 202, 1-8, 1992). In order to trace the Matrigel components incorporated in a basement membrane, Matrigel was labeled with biotin, and the process wherein the formation of a basement membrane was accelerated depending on the amount of Matrigel, and a basement membrane matrix being secreted in punctiform manner deposited in a sheet form, then a basement membrane development was observed by immunofluorescent staining of basement membrane components such as laminin, entactin, type IV collagen, perle can, and the electron micrographic monitoring. As a result, it has been found that stable exogenous laminin-1 and entactin are largely involved in the complete development of a basement membrane by the above-mentioned epithelial cells in vitro at the lower surface of alveolar epithelial cells (J. Cell Sci., 113:859-868, 2000).

[0009] Furuyama, A. ; et al. J. Cell Sci. Vol. 113, (2000) , pages 859-868 reports a study where cells formed a basement membrane in the presence of Matrigel. Matrigel is a major source of basement membrane components and Matrigel components were integrated into the basement membrane. In the absence of Matrigel, no basement membrane was formed even thought the cells have an ability to form a basement membrane.

[0010] Cagliero, E; et al. J. Clin. Invest. Vol. 82, (1988) , pages 735-8 shows that the gene expression of type IV collagen increases depending on the glucose concentration of a culture medium. Type IV collagen is one of the major components of a basement membrane from human vascular endothelial cells.

[0011] Further, an artificial skin formation promoting agent and skin basement membrane stabilizing agent comprising matrix metalloproteinase inhibitor or matrix metalloproteinase inhibitor and matrix protein production promoting agent; as well as a production method of artificial skin comprising adding matrix metalloproteinase inhibitor or matrix metalloproteinase inhibitor and matrix protein production promoting agent to an artificial skin formation medium are known (Japanese Laid-Open Patent Application No. 2001-269398).

[0012] The present inventors made a study on a process to form a basement membrane structure just beneath the basal surface of epithelial cells on a fibrous collagen matrix by the coculture with fibroblasts-embedded collagen gel, and by the culture in the presence of TGF-β or Matrigel. In the case of type II alveolar epithelial cells, it was confirmed that a basement membrane was formed in the following cases as shown in Fig. 1: the case wherein type II alveolar epithelial cells were cultured on pulmonary fibroblast-embedded collagen matrix in upper wells of culture inserts (collagen gel wherein fibrous cells are embedded) (T2-Fgel); the case wherein they were cultured on fibrous collagen substratum on upper wells in coculture with alveolar fibroblasts-embedded collagen matrix in lower wells (T2-fib-Fcm); the case wherein they were cultured on fibrous collagen substratum in upper wells in the presence of Matrigel coat on lower wells (T2-fib-MG); the case wherein they are cultured on fibrous collagen substratum in upper wells in the presence of growth factor TGF-β in upper and lower wells (T2-fib-TGFβ). However, it was also confirmed that type II alveolar epithelial cells were unable to constitute a basement membrane without the supply of, for example, a fibroblast, exogenous basement membrane components from Matrigel or a growth factor TGF- β, since the endogenous basement membrane components from type II alveolar epithelial cells are not enough for the cells to assemble a basement membrane structure effectively. However, followingproblems stillremained: aproblemof frequent troubles that, when fibroblasts secreting basement membrane components and a growth factor of TGF- β are used, gel contraction occurs during the culture, and the fibroblasts are peeled off from plastic membrane together with alveolar epithelial cells; a problem that reagents used to peel alveolar epithelial cells for the preparation of basemen membrane specimen tend to remain inside the gel if fibroblasts are embedded, and the wash procedure of such reagents is complicated; a problem that if some parts of cells remain, it may become an antigen; a problem that culture protocol for the formation of a basement membrane itself is complicated. Further, there has been also a problem that if fibroblasts alternative such as Matrigel and the like or a growth factor TGF-β is used as a resource of basement membrane component, said Matrigel and said growth factor TGF-β are expensive, and it is not advantageous in terms of the cost.

[0013] On the other hand, constitution of a basement membrane by endothelial cells (EC) was also considered. Although a basement membrane which is present just beneath the basal surface of endothelial cells also contributes to the expression and the maintenance of functions in endothelial cells, and a basement membrane of endothelial cells plays a role of a barrier when inflammatory cells invade into tissue from blood vessel, or when cancer cells metastasize, a basement membrane of vascular endothelial cells cannot be easily formed as for the case of epithelial cells. In the formation of a basement membrane by vascular endothelial cells, unlike the case of type II alveolar epithelial cells, as shown in Fig. 2, a basement membrane was not formed in the following cases with the exception of the case of (EC-Fgel) wherein the culture was carried out on fibroblast-embedded collagen matrix in upper wells; the case wherein the culture was carried out on fibrous collagen substratum in(on) upper wells in the presence of pulmonary fibroblasts-embedded collagen matrix in lower wells (EC-fib-Fcm) ; the case wherein the culture was carried out on fibrous collagen substratum in upper wells in the presence of Matrigel coat in lower wells (EC-fib-MG); the case wherein the culture was carried out on fibrous collagen matrix in upper wells (EC-fib).

[0014] In the meantime, the present inventors have reported that epithelial cells can be automatically detached from a basement membrane if alveolar epithelial cells which formed the above-mentioned basement membrane are treated with 0.18 M of hydrogen peroxide solution for 10 minutes, continued to culture for an additional day (Cell Struc. Func., 22, 603-614, 1997). In such process, however, it has been found to be a problem that there are cases that artificial human tissue having sufficient physiological activity such as function expression and maintenance of cells even if homogeneous or heterogeneous cells having a certain ability to form a basement membrane are seeded and cultured on said basement membrane since there are some cases wherein the detachment of cells from a basement membrane is insufficient, and a part of a basement membrane is damaged.

[0015] The object of the present invention 1 is to provide: a method for preparing a basement membrane in vitro which is extracellular matrices having a function to control morphology, differentiation, proliferation, motility, function expression and the like of cells, particularly a method for preparing a basement membrane with which cells having an ability to form a basement membrane such as epithelial cells, endothelial cells and the like can effectively activate an endogenous basement membrane component; a tissue model which can be obtained by the above-mentioned method for preparing a basement membrane in vitro; a test tissue kit including said tissue model.

[0016] Basement membrane components secreted from the cells having an ability to be assembled into a basement membrane by such as epithelial cells, endothelial cells and the like, or from fibroblasts, cannot automatically form a basement membrane structure by themselves, and needs a receptor which is considered to be localized on the surface of the cells having an ability to form a basement membrane such as epithelial cells, endothelial cells and the like, or particularly on the basal surface of said cells. The identity of said receptor, however, is not clearly known at the moment including the concern whether it is a single protein. The present inventors, in the course of a keen study on the mechanism of a basement membrane formation, obtained the knowledge that type II alveolar epithelial cells or vascular endothelial cells express receptors for sugar chains on their basal surface since type II alveolar epithelial cells or vascular endothelial cells can be adhered to a polymer having a certain sugar chain in vitro, namely a sugar chain which can localize a receptor having an activity to accumulate a basement membrane component on the basal surface of the cells having an ability to form a basement membrane, e.g. a sugar-chain coat having β-D-glucopyranosyl nonreducing end or 2-acetoamide-2-deoxy-β-D-glucopyranosyl nonreducing end. Secondly, as a result of culturing type II alveolar epithelial cells or vascular endothelial cells on fibrous collagen substratum coated with the above-mentioned polymer, the present inventors have found that a basement membrane having a barrier function similar to the one seen in in vivo is formed just beneath the type II alveolar epithelial cells or vascular endothelial cells. It was also found that although the supply of a basement membrane component such as a Matrigel and the like, and the addition of TGF- βwas not necessary for the formation of said basement membrane, if Matrigel was added, construction of a basement membrane was significantly accelerated, the culture term was long enough with a week, and the basement membrane became several fold thick. The knowledge that the above-mentioned fact is a result of that the receptor against the above-mentioned sugar chain was involved to progress the basement membrane formation was obtained. The present invention 1 has been completed based on such knowledge.

Disclosure of the Invention

[0017] The present invention relates to: a method for preparing a basement membrane in vitro wherein cells having an ability to form a basement membrane are cultured on a support structure with a sugar-chain coat which can localize a receptor having an activity to accumulate basement membrane components onto a basal surface of the cells having an ability to form a basement membrane according to claim 1; the method for preparing a basement membrane in vitro according to claim 1, wherein the cells having an ability to form a basement membrane are cultured on of a support structure with both opposite surfaces coated by a sugar chain (claim 2); the method for preparing a basement membrane in vitro according to claim 1 or 2, wherein a component secreted from the cells having an ability to form a basement membrane is used as a basement membrane component (claim 3) ; the method for preparing a basement membrane in vitro according to any of claims 1 - 3, wherein a sugar-chain coat, which can possibly adhere the cells having an ability to form a basement membrane onto a support structure through the binding between a sugar chain or a part of a sugar chain and a receptor, is used (claim 4) ; the method for preparing a basement membrane in vitro according to claim 4, wherein a sugar-chain coat is used, the sugar chain or a part of the sugar chain that binds to a receptor can be replaced by a basement membrane component (claim 5) ; the method for preparing a basement membrane in vitro according to any of claims 1-5, wherein one or more types of polymers selected from PV-GlcNAc, PV-CA and PV-Lam is used as the polymer having a sugar chain (claim 6).

[0018] The present invention is also related to: the method for preparing a basement membrane in vitro according to any of claims 1 - 6, wherein the cells having an ability to form a basement membrane are cocultured with fibroblasts or their alternatives (claim 7); the method for preparing a basement membrane in vitro according to any of claims 1 - 7, wherein the cells having an ability to form a basement membrane are cultured in the presence of one or more types of basement membrane components (claim 8); the method for preparing a basement membrane in vitro according to any of claims 1 - 8, wherein the cells having an ability to form a basement membrane are cultured in the presence of TGF-β (transforming growth factor) (claim 9) ; the method for preparing a basement membrane in vitro according to any of claims 1 - 9, wherein the cells having an ability to form a basement membrane are epithelial cells, endothelial cells or mesenchymal cells (claim 10) ; the method for preparing a basement membrane in vitro according to any of claims 1 - 10, wherein the cells and/or fibroblasts having an ability to form a basement membrane are basement membrane component-hyperexpressing cells into which genes of one or more types of a basement membrane component are transfected (claim 11) ; the method for preparing a basement membrane in vitro according to any of claims 1 - 11, wherein the support structure is a fibrous collagen (claim 12); a Basement membrane which can be obtained by the method for preparing a basement membrane in vitro according to any of claims 1 - 12 for use as a tissue model (claim 13) ; a test tissue kit including a Basement membrane which can be obtained by the method for preparing a basement membrane in vitro according to any of claims 1 - 12 (claim 14).

[0019] The present inventors found the following facts: if an surface active agent e.g. 0.1% Triton X-100 (Calbiochem-Novabiochem Corporation) is used for the cells wherein the basement membrane obtained by the above-mentioned present invention 1 is formed, lipid component of the cells is lysed by its surface activity; if an alkaline solution e.g. 10 - 50 mM of NH₃ is used, protein residues remained on the basement membrane of cells is lysed; if protease inhibitors cocktail (PIC) is used, degradation of a basement membrane by endogenous proteases and the like in lysosomes being liberated when cells are lysed is suppressed; if desired homogeneous or heterogeneous cells having an ability to form a basement membrane are seeded and cultured, a basement membrane specimen having a function to control morphology, differentiation, proliferation, motility, function expression and the like of cells can be obtained in the short term.

Brief Description of Drawings

[0020] 

Fig. 1 is a set of schematic diagrams showing the formation of a basement membrane by alveolar epithelial cells.

Fig. 2 is a set of schematic diagrams showing the formation of a basement membrane by pulmonary arterial vascular endothelial cells.

Fig. 3 is a set of schematic diagrams showing the formation of a basement membrane by the coculture of epithelial cells and endothelial cells.

Fig. 4 is a set of schematic diagrams showing the construction of a basement membrane and the constitution of an alveolar epithelial tissue.

Fig. 5 is a set of schematic diagrams showing the constitution of an endothelial tissue and an epithelial tissue using a reconstituted basement membrane specimen.

Fig. 6 is a drawing showing the adhesion specificity of type II alveolar cells on sugar chains.

Fig. 7 is a set of transmission electron micrographs of an alveolar epithelial tissue formed as a result of 2 -week culture of type II alveolar epithelial cells on the high density collagen fiber (fib*) coated with various kinds of PV-sugars.

Fig. 8 is a set of scanning electron micrographs of extracellular matrices beneath an alveolar epithelial tissue formed as a result of 2-week culture of type I I alveolar epithelial cells on the high density collagen fiber (fib*) coated with various kinds of PV-sugars.

Fig. 9 is a set of transmission electron micrographs of an alveolar epithelial tissue (left) and scanning electron micrographs of extracellular matrices beneath an alveolar epithelial tissue (right), both of which were formed as a result of 10-day coculture of type II alveolar epithelial cells with 25 µ1 of Matrigel coat on the bottom face of a culture dish on the high density collagen fiber (fib*) coated with various kinds of PV-sugars.

Fig. 10 is a set of scanning electron micrographs of extracellularmatrices which show the result of basement membrane formation of human pulmonary arterial vascular endothelial cells by the culture method shown in Fig. 2.

Fig. 11 is a set of scanning electron micrographs of extracellular matrices beneath vascular endothelial cell layers formed as a result of seeding human alveolar artery vascular endothelial cells on the high density collagen fiber (fib*) coated with various kinds of PV-sugars and coculturing for 2 weeks with a collagen gel wherein alveolar fibroblasts are embedded (EC-fib*-Fcm).

Best Mode of Carrying Out the Invention

[0021] As for the method for preparing a basement membrane of the present invention 1, there is no particular limitation as long as it is a method wherein the cells having an ability to form a basement membrane are cultured on a protein support structure with a specific sugar-chain coat, namely a sugar chain which can localize a receptor having an activity to accumulate a basement membrane component on the basal surface of the cells having an ability to form a basement membrane. The above-mentioned cells having an ability to form a basement membrane can be exemplified by epithelial cells, endothelial cells, mesenchymal cells and the like. The above-mentioned epithelial cells can be more particularly exemplified by epidermal cells, corneal epithelial cells, alveolar epithelial cells, mucosal epithelial cells of digestive organ system, renal glomerular epithelial cells, hepatic parenchymal cells and the like, the above-mentioned endothelial cells can be more particularly exemplified by renal glomerular capillary endothelial cells, pulmonary arterial vascular endothelial cells, placental venous vascular endothelial cells, or aortic endothelial cells and the like, and the mesenchymal cells can be more particularly exemplified by muscle cells, adipocytes, glial cells, Schwann cells and the like.

[0022] A basement membrane component such as laminin, type IV collagen, heparan sulfate proteoglycan (HSPG), entactin or the like is required for the preparation of a basement membrane, and respective cells having an ability to form a basement membrane secret basement membrane components. The basement membrane components secreted from such cells, however, are secreted from the basal surface (lower surface) of the cells toward the inside of extracellular matrices formed by fibrous collagen matrix. Therefore, most of the secreted basement membrane components are apart from the basal surface, and they diffuse from the basal surface into a culture medium, or they are degraded by proteases in mid course, as a result, usually they are not effectively utilized. However, in the method for preparing a basement membrane of the present invention 1, an endogenous basement membrane component secreted from cells having an ability to form a basement membrane such as the above-mentioned epithelial cells, endothelial cells and the like can be more effectively utilized by culturing the cells having an ability to form a basement membrane on a protein support structure with a specific sugar-chain coat, namely a sugar chain which can localize a receptor having an activity to accumulate a basement membrane component to the basal surface of the cells having an ability to form a basement membrane.

[0023] Further, if the method for present invention 1 for culturing the cells having an ability to form a basement membrane is conducted on the two opposite basal surface of the protein support structure with sugar-chain coat, for example, if fibrous collagen is generated on the both sides of porous membrane, two types of cells having an ability to form a basement membrane such as the combination of epithelial cells and vascular endothelial cells and the like are seeded and cultured on its both sides, the diffusion of endogenous basement membrane components secreted from the cells having an ability to form a basement membrane is prevented, so that effective utilization of basement membrane components can be enhanced. In other words, the basement membrane components secreted from the cells on one side reaches to the other cells positioned on the opposite side of fibrous collagen, and is blocked by the barrier without a gap due to the cell - cell junction (tight junction) formed by such cells, and do not diffuse into culture medium, and as a result, the effective utilization of basement membrane components can be enhanced. The upper stand of Fig. 3 schematically shows the following: the formation of a basement membrane by the coculture of epithelial cells and vascular endothelial cells through collagen fiber in the presence of fibroblasts embedded in collagen gel (left); the formation of a basement membrane by the coculture of epithelial cells and vascular endothelial cells through a thin membrane of collagen fiber which is a support structure with the sugar-chain coat of the present invention (middle); the formation of a basement membrane by the coculture of epithelial cells and fibroblasts through collagen fiber (right). Further, the lower stand of Fig. 3 shows the conditions wherein the cell tissues which are not needed such as a vascular endothelial tissue (left), epithelial tissue (middle), fibroblasts (right) are mechanically exfoliated. As for the combination of these cells, the following combinations are considered: epithelial cells and vascular endothelial cells; epithelial cells and epithelial cells; endothelial cells and endothelial cells; epithelial cells or endothelial cells and some mesenchymal cells, etc. The above-mentioned support structure can be exemplified by porous PET membrane, elastin (polymer) membrane, as well as fibrous collagen membrane, fibrous collagen matrix.

[0024] Further, in the method for preparing a basement membrane of the present invention 1, in order that a basement membrane can be prepared in the short term using even exogenous basement membrane components in addition to endogenous basement membrane components secreted from these cells having an ability to form a basement membrane, it is also possible to coculture with fibroblasts secreting basement membrane components and TGF-β, or more preferably with conditioned culture medium of fibroblasts or a fibroblast substitute such as Matrigel richly containing basement membrane components. Besides, in order that a basement membrane can be prepared in the short term in the same manner, it is also possible to culture the cells having an ability to form a basement membrane in the presence of one or more types of basement membrane components separately prepared such as laminin, type IV collagen, heparan sulfate proteoglycan (HSPG), entactin and the like, or in the presence of TGF-β. As for the above-mentioned laminin and HSPG, commercially available products can be used, and as for type IV collagen, the one extracted using acetic acid from bovine lens capsule can be advantageously used.

[0025] Instead of the above-mentioned method wherein a basement membrane component such as laminin, type IV collagen, heparan sulfate proteoglycan (HSPG), entactin and the like, or TGF-β as mentioned above is used, which costs highly, a basement membrane component hyperexpressing cells into which genes of one or more types of basement membrane components such as laminin, type IV collagen and the like are transfected, or the growth factor hyperexpressing cells wherein the TGF-β genes are transfected can be selectively used as the cells having an ability to form a basement membrane and fibroblasts used for the method for preparing a basement membrane of the present invention 1. Particularly, a basement membrane specimen having a specific function can be obtained using the cells biosynthesizing and secreting a single molecular species of a basement membrane component by the gene manipulation.

[0026] As for the specific sugar chain for the method for preparing a basement membrane of the present invention 1, namely, the sugar chain which can localize a receptor having an activity to accumulate a basement membrane component onto the basal surface of the cells having an ability to form a basement membrane, it is preferable to use a sugar chain which can adhere the cells having an ability to form a basement membrane onto a support structure by the bonding of the sugar chain or a part of the sugar chain and the above-mentioned receptor, particularly a sugar chain wherein the sugar chain or a part of the sugar chain bonded to the receptor can be replaced by the above-mentioned basement membrane component. As for the support structure with a sugar chain of the present invention, it is preferable to be an integral molding body having a sugar chain, or a support structure coated with polymer having a sugar chain. The polymer having such sugar chain can be exemplified by a polymer having a sugar chain having β-D-glucopyranosyl nonreducing end or 2-acetoamide-2-deoxy-β-D-glucopyranosyl nonreducing end. Further, the polymer having a sugar chain having the β-D-glucopyranosyl nonreducing end can be particularly exemplified by PV-CA, PV-Lam and the like, and the polymer having a sugar chain having the 2-acetoamide-2-deoxy-β-D-glucopyranosyl nonreducing end can be particularly exemplified by a polymer macromolecule wherein oligosaccharides are introduced into a vinyl monomer such as PV-GlcNAc and the like (PV-sugar). The mixture of more than one types of these PV-sugars can also be used as well as a single type independently, and these PV-sugars are commercially available.

[0027] The support structure (with a sugar-chain coat) for the method for preparing a basement membrane of the present invention 1 can be exemplified by a fibrous collagen matrix, porous PET membrane, polystyrene plate, (synthetic) elastin polymer, bioabsorbable polymer and the like, however, a fibrous collagen matrix is more preferable in terms of maintaining the diffusion of nutritive salts and waste products. As for the fibrous collagen matrix, high density matrix of collagen gel contracted by fibroblasts can also be used. In this case, it is also possible to add ascorbic-2-phosphate (Asc-P) in order to enhance the synthesis of collagen. Further, a fibrous collagen matrix, which is constructed by leaving a neutral type I collagen solution at rest in CO₂ incubator to incubate it, and air-drying a resulting polymerized gel at room temperature, can also be used. It is preferable to use a bioabsorbable polymer since it is possible to transplant while maintaining the basement membrane structure supported by a support structure. Said bioabsorbable polymer can be particularly exemplified by polyglycolic acid, poly-L-lactic acid, L-lactic acid/glycol acid copolymer, glycol acid/ε-caprolactone copolymer, L-lactic acid/ε-caprolactone copolymer, poly-ε-caprolactone and the like.

[0028] As for the tissue model of the present invention 1, there is no particular limitation as long as it is a tissue containing cell layers which can be obtained by the method for preparing a basement membrane of the above-mentioned present invention and a basement membrane beneath the cell layers. For example, it can be particularly exemplified by epidermal tissue model, corneal epithelial tissue model, alveolar epithelial tissue model, respiratory epithelial tissue model, renal glomerular tissue model, hepatic parenchymal tissue model, pulmonary arterial vascular endothelial tissue model and the like. The tissue model of the present invention 1 has a barrier function original to a living body since it has a cell layer and a basement membrane structure same as those of a living body, therefore, it can be advantageously used particularly for applying to pharmacological test and toxicity test of chemical substances and the like compared to conventional artificial skin and the like which does not maintain barrier function. For example, it is possible to test the safety and toxicity of a test substance against an epithelial tissue by letting a test substance present onto the cell layer of an epithelial tissue model and measuring the electric resistance between the upper surface and the basal surface of the epithelial cells. The safety and toxicity of a test substance can be evaluated since electric resistance lowers if the test substance caused a lesion, even it is a minor one, to an epithelial tissue. It is also possible to test the safety and toxicity of a test substance against an epithelial tissue by letting a test substance present onto the cell layer of an epithelial tissue model, and monitoring the condition of the epithelial tissue and a basement membrane using a scanning electron microscope or a transmission electron microscope.

[0029] As for the test tissue kit of the present invention 1, there is no particular limitation as long as it is a kit containing a tissue model which can be obtained by the method for preparing a basement membrane of the present invention 1, for example, it can be exemplified by a test kit for pharmacological test, toxicity test and the like containing the tissue model structure of the present invention 1, and a tissue model construction kit for pharmacological test, toxicity test and the like. The tissue model construction kit can be particularly exemplified by a kit containing the following: certain cells comprising a test tissue; en extracellular matrix such as a fibrous collagen and the like coated with PV-GlcNAc and the like wherein said cells are seeded; a standard culture medium such as DMEM culture medium and the like for culturing the above-mentioned cells; Matrigel, type IV collagen solution, buffer solution and the like as a supplemental component. The course of the construction of a test tissue using said tissue model construction kit is shown in Fig. 4.

[0030] A basement membrane specimen (rBM; reconstructed basement membrane) can be further constructed from the tissue model of the present invention 1 by removing the cells having an ability to form a basement membrane from a basement membrane. Although there is no limitation to the method for removing the cells having an ability to form a basement membrane from a basement membrane, the method for removing epithelial cells and endothelial cells without damaging the basement membrane is preferable, and it is not preferable to remove the cells using a protease such as trypsin and the like, since the basement membrane itself will also be degraded. The method for removing epithelial cells and endothelial cells without damaging the basement membrane can be exemplified by a known method wherein the cells which formed a basement membrane such as alveolar epithelial cells and the like are treated with 0.18 M of hydrogen peroxide for 10 minutes, the culture was continued for 1 day thereafter, and cells are automatically detached from the basement membrane)

[0031] The present invention will be more particularly explained in the following with reference to the examples, but the technical scope of the invention will not be limited to these examples. Example 1 (Epithelial cells, endothelial cells and the like forming a basement membrane)

[0032] As for epithelial cells, type II alveolar epithelial cells (obtained from rats transfected with SV40-large T antigen genes; T2 cells) which were provided by Dr. A. Clement, Hôpital Armand Trousseau, Paris (Clement et al., Exp. Cell Res. , 196: 198-205, 1991) were cultured in DMEM (Dulbecco's modified Eagle medium) wherein 10 mM of 2-[4-(2-hydroxyethyl)-1-piperazinyl] ethanesulfonic acid (HEPES) (pH 7.2), 10% fetal bovine serum (FBS; Hyclone Laboratories Inc., Logan, Utah), penicillin, and streptomycin are added, in the atmospheric condition of air 95%/CO₂ 5%, and used. As for endothelial cells, human pulmonary arterial vascular endothelial cells (HPAE cells) purchased from Clonetics were cultured in culture medium of MCDB 131 alone wherein 10 mM of HEPES (pH 7. 2), 2% FBS, growth factor, penicillin, and streptomycin are added, or culture medium of equal mixture of MCDB 131 and DMEM, in the atmospheric condition of air 95%/CO₂ 5%, and used. As for fibroblasts, theonepreparedfrompulmonary fibroblasts derived from male rats Jcl: Fischer 344 according to the method previously described (CELL STRUCTURE AND FUNCTION 22: 603-614, 1997) and the human pulmonary fibroblasts purchased from Clonetics were used.

Example 2 (Preparation of fibrous collagen gel)

[0033] Collagen gel fiber was prepared on the model of dense matrix of collagen gel usually constituted by fibroblasts. Type I neutral collagen solution in DMEM (pH 7.2) (0.3 - 0.5 mg/ml of type I collagen obtained from 0.42 ml of bovine dermis by acid extraction; Koken Co. , Tokyo) were added to 4.3 cm² of cultured fibroblast layer together with polyethylene terephthalate ester membrane of 6-well culture plate (Becton Dickinson Labware, Franklin Lakes, NJ), and incubated in CO₂ incubator for a few hours - 24 hours, then allowed to gelling. This gel was air-dried and compressed at room temperature for 24 - 48 hours, and used as high-density collagen fiber (fib). As for the above-mentioned fibroblasts, pulmonary fibroblasts derived from male rats Jcl: Fischer 344 were prepared according to the method previously described (CELL STRUCTURE AND FUNCTION 22: 603-614, 1997).

Example 3 (Constitution of tissue model 1)

[0034] The methods for forming epithelial tissues and endothelial tissues having a basement membrane beneath the type II alveolar epithelial cells and vascular endothelial cell layers are shown in Fig. 1 and Fig. 2 respectively. In order to constitute most basic tissue model, the above-mentioned epithelial cells (T2) or endothelial cells (HPAEC) were seeded directly on the collagen gel wherein fibroblasts were embedded, and cultured for 2 weeks (T2-Fgel in Fig. 1, EC-Fgel in Fig. 2). Further, in order to form epithelial tissue and endothelial tissue having a basement membrane using the above-mentioned fib as culture matrix, epithelial cells (T2) or endothelial cells (HPAEC) were directly seeded on fib and cultured for 2 weeks (T2-fib-Fcm, T2-fib-MG and T2-fib-TGFβ in Fig. 1). In Fig. 1, Fcm shows the coculture with collagen gel wherein fibroblasts are embedded (Fgel), MG shows the culture wherein the bottom of culture plate is coated with Matrigel 200 µl (Becton Dickinson), and TGFβ shows the culture wherein 1 ng/ml of TGFβ is added.

Example 4 (Confirmation of the presence of a receptor in epithelial cells)

[0035] 96-well polystyrene plate (Becton Dickinson) were coated with various kinds of PV-sugars (Seikagaku Corporation) with 10 µg/ml concentration according to the protocol of the manufacturer, 1 × 10⁴ of type II rat alveolar epithelial cells were seeded thereon, and incubated in DMEM wherein 10 mM HEPES (pH 7.2) and 1% FBS were added in CO₂ incubator at 37° C for 24 - 48 hours. After the incubation, the cells were stained with crystal violet and the adhesiveness to various kinds of PV-sugars was investigated by measuring the absorbence of 595 nm and setting the same as cell number. Further, cell adhesion of cell adhesion factor against fibronectin (FN) and vitronectin (VN) coats were also conducted simultaneously as a control experiment. The results are shown in Fig. 6. The abscissa axis in Fig. 6 shows various kinds of PV-sugars of nonreducing end sugar chain (GlcNAc; 2-acetoamide-2-deoxy-β-D-glucopyranosyl, Lam; β-D-glucopyranosyl-(1→3), CA; β-D-glucopyranosyl-(1→4), LA; β-D-glucopyranosyl, MA; α-D-glucopyranosyl, Man; β-D-mannopyranosyl, MEA; α-D-galactopyranosyl). Fig. 6 shows that type II alveolar epithelial cells have strong adhesiveness to: PV-GlcNAc with sugar chain having 2-acetoamide-2-deoxy-β-D-glucopyranosyl nonreducing end; PV-CA or PV-Lam with sugar chain having β-D-glucopyranosyl nonreducing end; PV-LA with sugar chain having β-D-galactopyranosyl nonreducing end. These results show that type II alveolar epithelial cells express a receptor against these sugar chains on their basal surface.

Example 5 (Constitution of tissue model 2; preparation of a basement membrane by type II alveolar epithelial cells)

[0036] As for the preparation of a basement membrane, a culture insert comprised of a lower well, and an upper well which can be placed in said lower well on concentric circle and which has a PET membrane in its bottom was used (see Fig. 1). On the PET membrane at the bottom part of upper well, type II alveolar epithelial cells were cultured at 37° C in the presence of 5% CO₂ for 2 weeks on the support structure(fib*) wherein hiqh-densitycollagenfiber (fib) constructed by the method shown in Example 2 was coated with PV-GlcNAc, PV-CA or PV-Lam lysed in DMEM with concentration of 10 µg/ml. In this culture, collagen gel wherein fibroblasts are embedded (Fgel), Matrigel (MG), or TGFP were not added to culture system, DMEM wherein 10 mM of HEPES (pH7.2), 1% FBS, and 0.2 mM of ascorbic acid-2-phosphate (Asc-P) were added was used for the culture solution. Transmission electron micrographs of an alveolar epithelial tissue thus formed are shown in Fig. 7, and scanning electron micrographs of extracellular matrices beneath an exposed alveolar epithelial tissue as a result of removing type II alveolar epithelial cell layers on the surface of an alveolar epithelial tissue thus formed according to the method shown in Example 8 (to be hereinafter described) are shown in Fig. 8.

[0037] In Fig. 7, the bold arrows show the basement membrane lamina densa, the small arrows show the old basement membranes which were formed at the beginning of the culture, and a part of which is being degraded, and the arrowheads show the regions wherein a basement membrane is not formed (scale length is 1 µm) respectively. Further, in the untreatment of PV-sugar (Cont) in Fig. 8, only the spots existing on fib (collagen fiber, outlined bold arrow) where secretion of epithelial cells are accumulated (*) were confirmed, but with treatment of PV-GlcNAc, PV- Lam or PV-CA, a basement membrane is flatly formed (in response to the bold arrows in Fig. 7), in PV-Lam treatment, lower part of collagen fiber (outlined bold arrow) are glimpsed from the defective window of a basement membrane part of which are lost when type II alveolar epithelial cell layer is removed (scale length is 1 µm). Based on these results, it has been confirmed that if the culture is conducted on high-density collagen fibrous support structure coated with PV-GlcNAc having 2-acetoamide-2-deoxy-β-D-glucopyranosyl nonreducing end, PV-CA or PV-Lam having β-D-glucopyranosyl nonreducing end (GlcNAc-fib*, CA-fib*, Lam-fib*); an alveolar epithelial tissue wherein a basement membrane is formed beneath type II alveolar epithelial cell layer is constituted. Further, although type II alveolar cells adhere to PV-LA having β-D-galactopyranosyl nonrducing end (Fig. 6), a basement membrane was not formed (Figs. 7 and 8). This fact shows that cell adhesiveness to sugar chain is a necessary condition but not a sufficient condition for the formation of a basement membrane.

Example 6 (The acceleration effect for a basement membrane formation by Matrigel)

[0038] As shown by T2 -fib-MG in Fig. 1, when lower well are coated with Matrigel 200 µl, and alveolar epithelial cells are cultured on high-density collagen fiber (fib) for 2 weeks, a basement membrane is formed beneath epithelial cells. However, if the amount of Matrigel is less than 50 µl, a basement membrane is not formed (J. Cell Sci. , 113:589-868, 2000). Even in this case, if high-density collagen fiber (fib) are constructed according to the method shown in Example 2, and culture matrix (fib*) coated with PV-GlcNAc, PV-CA or PV-Lam are used according to the method shown in Example 5, a basement membrane is formed beneath type II alveolar epithelial cell layer after the 10-days culture. Fig. 9 shows the transmission electron micrographs of an epithelial tissue (left side: untreated, and PV-GlcNAc, PV-CA coating) formed as a result of 10-days coculture with Matrigel 25 µl coating the bottom of culture plate on the high density collagen fiber (fib*) coated with various kinds of PV-sugars, and scanning electron micrographs (right side: untreated, and PV-GlcNAc, PV-CA coating) of the result of removing alveolar epithelial cell layers according to the method shown in Example 8 (to be hereinafter described) and exposing a basement membrane structure just beneath them to the surface (the meanings of the marks and scale are same as in Example 5). Based on these results, it has been confirmed that even if the amount of Matrigel is insufficient, alveolar epithelial tissues wherein a basement membrane is formed can be constituted just beneath type II alveolar epithelial cell layer using high-density collagen fibrous support structurecoated with PV-GlcNAc or PV-CA (GlcNAc-fib*, CA-fib*).

Example 7 (Preparation of a basement membrane by human pulmonary arterial vascular endothelial cells)

[0039] Human pulmonary arterial vascular endothelial (HPAE) cells were cultured according to the method shown in Fig. 2. More particularly, the culture was conducted in the following way: direct culture on the collagen gel wherein human fibroblasts are embedded(Fgel)(EC-Fgel); culture on high-density collagen fiber (fib) in the presence of Fgel (EC-fib-Fcm) ; coculture with 200 µl of Matrigel on fib (EC-fib-MG); culture on fib (EC-fib). After the culture, HPAE cell layer on the surface was removed according to the method for referential example 1 (to be hereinafter described), and extracellular matrix structure beneath the cells were monitored by scanning electron microscope (Fig. 10). Although a basement membrane was formed in the case of EC-Fgel, existing collagen fiber was exposed in the case of EC-fib-Fcm, EC-fib-MG, and EC-fib and a basement membrane was not formed as in the case of T2 cells (T2-fib-Fcm, T2-fib-MG) (the outlined bold arrows show collagen fiber. * shows secretion deposited between collagen fibers. Scale length is 1 µm). Accordingly, culture system of EC-fib-Fcm was used for the culture on high-density collagen fibrous support structure (fib*) coated with PV-sugar as in the case of type II alveolar epithelial cells of Example 5. After the culture, HPAE cell layer on the surface was removed according to the method for referential Example 1, extracellular matrix structure exposed just beneath the cells was monitored by scanning electron microscope (Fig. 11). In the case of PV-GlcNAc and PV-CA coating, formation of a basement membrane was confirmed. In the case of PV-Lam coating, the formation of a basement membrane was incomplete. In the case of PV-sugar untreated (Cont), and PV-LA, PV-MA, PV-Man, PV-MEA treatments, secretion of epithelial cells were accumulated (*) on the existing collagen fiber (outlined bold arrows), however, a basement membrane was not formed. Based on these results, it has been confirmed that if fib* coated with PV-GlcNAc, PV-CA (GlcNAc-fib*, CA-fib*) are used, human pulmonary arterial vascular endothelial tissue wherein a basement membrane is formed just beneath human pulmonary arterial vascular endothelial cell layer was constituted.

Example 8 (Construction of a basement membrane specimen wherein an alveolar epithelial cell layer is removed and a basement membrane is exposed)

[0040] As schematically shown in Fig. 5, type II alveolar epithelial cell layer was exfoliated from tissue model (T2-fib-MG), a basement membrane specimen wherein a basement membrane is exposed was constructed, rat respiratory epithelial cells or human pulmonary arterial vascular epithelial cells were seeded on such constructed basement membrane structure, and respiratory epithelial tissue and vascular epithelial tissue were constructed. Firstly, 2 ml of 0.1% of Triton X-100 (surface active agent) in isotonic phosphate buffer (pH 7.2; PBS (-)) containing protease inhibitorscocktail(PIC,PeptideInstitute, Inc., Osaka) was used to lyse and elute the lipid components of epithelial cells of the type II alveolar epithelial tissue on a culture insert of upper well, and simultaneously, the procedure to lyse protein residues of the cells remained on the basement membrane surface with coexisting 50 mM of NH₃ was conducted. This procedure of Triton X-100 and NH₃ treatment was repeated twice (proteins of a basement membrane should not be lysed), then an alveolar epithelial cell layer was exfoliated from the basement membrane and the basement membrane specimen wherein a basement membrane is exposed was prepared, followed by another washing with PBC (-) solution containing PIC to remove surface active agent and alkaline solution.

Industrial Applicability

[0041] According to the method for preparing a basement membrane of the present invention 1, epithelial tissue model or endothelial tissues model having a basement membrane structure can be constituted in the moderate condition by using a polymer having specific sugar chain, and it has become possible for the basement membrane structure prepared in such method to form the epithelial tissue and endothelial tissue of other tissues. These basement membrane structure and epithelial tissue/endothelial tissue can be utilized for the purpose of medical/biological study, for the purpose of transplantation/therapy as an artificial blood vessel, an artificial lung, an artificial liver, an artificial kidney, an artificial skin, an artificial cornea and the like, and for the purpose of pharmacological test and toxicity test.

Claims

1. A method for preparing a basement membrane in vitro wherein cells having an ability to form a basement membrane are cultured on a support structure coated with a polymer having a sugar chain, wherein the sugar chain coat can localize a receptor having an activity to accumulate basement membrane components onto a basal surface of the cells having an ability to form a basement membrane and the sugar chain has β-D-glucopyranosyl non reducing end or 2-acetoamide-2-deoxy-β-D-glucopyranosyl non reducing end.

2. The method for preparing a basement membrane in vitro according to claim 1, wherein the cells having an ability to form a basement membrane are cultured on a support structure with both opposite surfaces coated with a polymer having a sugar chain.

3. The method for preparing a basement membrane in vitro according to claim 1 or 2, wherein a component secreted from the cells having an ability to form a basement membrane is used as a basement membrane component.

4. The method for preparing a basement membrane in vitro according to any of claims 1 - 3, wherein a sugar-chain coat, which can possibly adhere the cells having an ability to form a basement membrane onto a support structure through the binding between a sugar chain or a part of a sugar chain and a receptor, is used.

5. The method for preparing a basement membrane in vitro according to claim 4, wherein a sugar-chain coat is used, the sugar chain or a part of the sugar chain that binds to a receptor can be replaced by a basement membrane component.

6. The method for preparing a basement membrane in vitro according to any one of claims 1-5, wherein one or more types of polymers selected from PV-GlcNAc, PV-CA and PV-Lam is used as the polymer having a sugar chain.

7. The method for preparing a basement membrane in vitro according to any of claims 1-6, wherein the cells having an ability to form a basement membrane are cocultured with fibroblasts or their alternatives.

8. The method for preparing a basement membrane in vitro according to any of claims 1-7, wherein the cells having an ability to form a basement membrane are cultured in the presence of one or more types of basement membrane components.

9. The method for preparing a basement membrane in vitro according to any of claims 1-8, wherein the cells having an ability to form a basement membrane are cultured in the presence of TGF-β (transforming growth factor).

10. The method for preparing a basement membrane in vitro according to any of claims 1 - 9, wherein the cells having an ability to form a basement membrane are epithelial cells, endothelial cells or mesenchymal cells.

11. The method for preparing a basement membrane in vitro according to any of claims 1 - 10, wherein the cells and/or fibroblasts having an ability to form a basement membrane are basement membrane component-hyperexpressing cells into which genes of one or more types of a basement membrane component are transfected.

12. The method for preparing a basement membrane in vitro according to any of claims 1-11, wherein the support structure is a fibrous collagen.

13. A basement membrane obtained by the method according to any of claims 1 - 12 for use as a tissue model.

14. A test tissue kit including a basement membrane obtained by the method according to any of claims 1 - 12.

Ansprüche

1. Verfahren zum Erzeugen Basalmembran in vitro, bei dem Zellen, die eine Fähigkeit aufweisen, eine auszubilden, auf einer Trägerstruktur kultiviert werden, die mit einem Polymer beschichtet ist, welches eine Zuckerkette aufweist, wobei die Zuckerkettenbeschichtung einen Rezeptor lokalisieren kann, der eine Aktivität aufweist, um Basalmembrankomponenten auf einer Basaloberfläche der Zellen, die eine Fähigkeit aufweise, eine Basalmembran auszubilden, zu akkumulierten, und wobei die Zuckerkette ein nicht-reduzierendes β-D-Glukopyranosyl-Ende oder ein nicht-reduzierendes 2-Acetoamid-2-desoxy-β-D-glukopyranosyl-Ende aufweist.

2. Verfahren zum Erzeugen einer Basalmembran in vitro nach Anspruch 1, wobei die Zellen, die eine Fähigkeit aufweise, eine Basalmembran auszubilden, auf einer Trägerstruktur mit zwei gegenüberliegenden Oberflächen, die mit einem Polymer, das eine Zuckerkette aufweiset, beschichtet sind, kultiviert werden.

3. Verfahren zum Erzeugen einer Basalmembran in vitro nach Anspruch 1 oder 2, wobei eine Komponente, die von den Zellen abgeschieden wird, die eine Fähigkeit aufweise, eine Basalmembran auszubilden, als eine Basalmembrankomponente verwendet wird.

4. Verfahren zum Erzeugen einer Basalmembran in vitro nach einem der Ansprüche 1 bis 3, wobei eine Zuckerkettenbeschichtung, die möglicherweise die Zellen, die eine Fähigkeit aufweise, eine Basalmembran auszubilden, auf einer Trägerstruktur über die Windung zwischen einer Zuckerkette oder einem Teil einer Zuckerkette und einem Rezeptor anheften kann, verwender wird.

5. Verfahren zum Erzeugen einer Basalmembran in vitro nach Anspruch 4, wobei eine Zuckerkettenbeschichtung verwendet wird, wobei die Zuckerkette oder ein Teil der Zuckerkette, der an einen Rezeptor bindet, ersetzt werden kann durch eine Basalmembrankomponente.

6. Verfahren zum Erzeugen einer Basalmembran in vitro nach einem der Ansprüche 1 bis 5, wobei einer oder mehrere Typen von Polymeren, die unter PV-GtcNAc, PV-CA und PV-Lam ausgewählt sind, als das Polymer; das eine Zuckerkette aufweist, verwendet werden.

7. Verfahren zum Erzeugen einer Basalmembran in vitro nach einem der Ansprüche 1 bis 6, wobei die Zellen, die eine Fähigkeit aufweise, eine auszubilden, cokultiviert werden mit Fibroblasten oder deren Alternativen.

8. Verfahren zum Erzeugen einer Basalmembran in vitro nach einem der Ansprüche 1 bis 7, wobei die Zellen, die eine Fähigkeit aufweisen, eine Basalmembran auszubilden, in der Gegenwart von einer oder mehreren Typen von Basatmembrankomponenten kultiviert werden.

9. Verfahren zum Erzeugten einer Basalmembran in vitro nach einem der Ansprüche 1 bis 8, wobei die Zellen, die eine Fähigkeit aufweisen, eine Basalmembran auszubilden, in der Gegenwart von TGF-β (transformierter Wachstumsfaktor) kultiviert werden.

10. Verfahren zum Erzeugern einer Basalmembran in vitro nach einem der Ansprüche 1 bis 9, wobei die Zellen, die eine Fähigkeit aufweise, eine Basalmembran auszubilden, Epithelzellen, Endothelzellen oder mesenchymal Zellen sind.

11. Verfahren zum Erzeugen einer Basalmembran in vitro nach einem der Ansprüche 1 bis 10, wobei die Zellen und/oder Fibroblasten, die eine Fähigkeit aufweisen, eine Basalmembran auszubilden, Basalmembrankomponenten-überexprimierende Zellen sind, in die Gene von einem oder mehreren Typen von Basalmembrankomponenten transfiziert wurden.

12. Verfahren zum Erzeugen einer Basalmembran in vitro nach einem der Ansprüche 1 bis 11, wobei die Trägerstruktur Faserkollagen ist.

13. Basalmembran, die durch das Verfahren nach einem der Ansprüche 1 bis 12 erhalten wurde für die Verwendung als eine Gewebemodell.

14. Testgewebe-Kit, umfassen eine Basalmembran, die durch das Verfahren nach einem der Ansprüche 1 bis 12 erhalten wurde.

Revendications

1. Procédé de préparation d'une membrane basale in vitro, dans lequel les cellules ayant une capacité à former une membrane basale sont cultivées sur une structure de support revêtue d'un polymère ayant une chaîne de sucre, dans lequel le revêtement de chaîne de sucre peut localiser un récepteur ayant une activité permettant d'accumuler les composants de la membrane basale sur une surface basale des cellules ayant une capacité à former une membrane basale et la chaîne de sucre a une extrémité β-D-glucopyranosyle non réductrice ou une extrémité 2-acétoamide-2-désoxy-β-D-glucopyranosyle non réductrice.

2. Procédé de préparation d'une membrane basale in vitro selon la revendication 1, dans lequel les cellules ayant une capacité à former une membrane basale sont cultivées sur une structure de support, avec les deux surfaces opposées revêtues d'un polymère ayant une chaîne de sucre.

3. Procédé de préparation d'une membrane basale in vitro selon la revendication 1 ou 2, dans lequel un composant secrété par les cellules ayant une capacité à former une membrane basale est utilisé comme composant de membrane basale.

4. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 3, dans lequel un revêtement de chaîne de sucre, qui peut éventuellement adhérer aux cellules ayant une capacité à former une membrane basale sur une structure de support à travers la liaison entre une chaîne de sucre ou une partie d'une chaîne de sucre et d'un récepteur, est utilisé.

5. Procédé de préparation d'une membrane basale in vitro selon la revendication 4, dans lequel un revêtement de chaîne de sucre est utilisé, la chaîne de sucre ou une partie de la chaîne de sucre qui se lie à un récepteur pouvant être remplacée par un composant de membrane basale.

6. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 à 5, dans lequel un ou plusieurs types de polymères choisis parmi le PV-GlcNAc, PV-CA et PV-Lam est (sont) utilisé(s) comme polymère ayant une chaîne de sucre.

7. Procédé de préparation d'une membranes basale in vitro selon l'une quelconque des revendications 1 à 6, dans lequel les cellules ayant une capacité à former une membrane basale sont co-cultivées avec des fibroblastes ou leurs variantes.

8. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 à 7, dans lequel les cellules ayant une capacité à former une membrane basale sont cultivées en présence d'un ou plusieurs types de composants de membrane basale.

9. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 à 8, dans lequel les cellules ayant une capacité à former une membrane basale sont cultivées en présence de TGF-β (facteur de croissance transformant).

10. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 à 9, dans lequel les cellules ayant une capacité à former une membrane basale sont des cellules épithéliales, des cellules endothéliales ou des cellules mésenchymateuses.

11. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 à 10, dans lequel les cellules et/ou les fibroblastes ayant une capacité à former une membrane basale sont des cellules hyper-exprimant le composant de membrane basale, dans lesquelles les gènes d'un ou plusieurs types d'un composant de membrane basale sont transfectés.

12. Procédé de préparation d'une membrane basale in vitro selon l'une quelconque des revendications 1 à 11, dans lequel la structure de support est un collagène fibreux.

13. Membrane basale obtenue par le procédé selon l'une quelconque des revendications 1 à 12, utiliser comme modèle de tissu.

14. Kit de tissu de test comprenant une membrane basale obtenue par le procédé selon l'une quelconque des revendications 1 à 12.

Drawing